Melanotan II 10mg (Euro-Pharmacies, Europe)

Melanotan II was initially created as a potential preventive treatment for various types of skin cancer. The idea was that by artificially activating the body's tanning process in individuals who are at a high risk of developing skin cancer due to sun exposure, it might reduce their likelihood of getting the disease later in life.

In addition to its ability to provide a tan without requiring significant sun exposure, along with enhanced sexual performance and/or desire, Melanotan II may also aid in appetite reduction by targeting an appetite-suppression receptor in the brain. While this effect isn't overwhelming, many users find it noticeable and beneficial. The duration of the tanning effect after stopping the drug will depend on various factors; however, most users find that the tan achieved fades and becomes less noticeable within four to eight weeks after discontinuing the drug.

For most people, during the loading phase with the hormone, a dosage of around 0.015 to 0.02 milligrams per kilogram of body weight per injection should be adequate. These injections can be administered anywhere from twice daily to as infrequently as once every other day or longer. During the maintenance phase, many individuals will discover that a dose of approximately 0.01 milligrams per kilogram of body weight given once every few days is sufficient to sustain the hormone's effects.